Early research (Phase 1)Study completedNCT00607230
What this trial is testing
Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics
Who this might be right for
Type 1 Diabetes Mellitus
Massachusetts General Hospital 25